Investing.com -- Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

We recently published 10 Stocks That Vanished in Value Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing ...

Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...

Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...

We recently published 10 Big Names Bleed Double Digits. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing ...

Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what ...

Investing.com -- Hims & Hers Health (NYSE:HIMS) stock dropped 2.6% on Friday following reports that the Federal Trade Commission has been investigating the telehealth company’s business practices for ...

Het nieuwe koersdoel van $48 van TD Cowen is gebaseerd op ongeveer 4x FY2 EV/Sales, hoewel het bedrijf zijn Hold-advies handhaafde vanwege de geïdentificeerde korte termijn dynamiek en verhoogde ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock lately, following its bumpy ride over recent months. The San Francisco, CA-based health and ...

Investing.com - Hims Hers Health (NYSE: HIMS) rapporteerde op maandag voor het tweede kwartaal een winst die hoger is dan verwacht en een omzet die achterblijft bij de voorspellingen.